Medical News Today

Rebif and cost

Rebif (interferon beta-1a) is a brand-name injectable solution prescribed for multiple sclerosis (MS) in adults. The medication comes in prefilled syringes and auto ...
Healthline

Side Effects of Rebif: What You Need to Know

Rebif (interferon beta-1a) is a prescription drug used to treat types of multiple sclerosis. Rebif can cause side effects that range from mild to serious. Examples ...
Business Wire

New Safety Data on Pregnancy Outcomes in Women with MS Using Interferon Beta, Including Rebif ®, Before and During First Trimester

DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced that new pregnancy outcomes data in women with MS treated with interferon beta (IFN β), including ...
Healthline

Rebif: Pregnancy and Breastfeeding Information

Rebif (interferon beta-1a) is a prescription drug used to treat some types of multiple sclerosis (MS). Rebif may be safe to use while pregnant or breastfeeding. Keep ...
FierceBiotech

PRESS RELEASE: New Formulation of Multiple Sclerosis Treatment Rebif(R) Approved in European Union

- New Formulation of Rebif(R) Designed to Improve Injection Tolerability Merck Serono, a division of Merck KGaA, announced today that the European Commission has ...
FiercePharma

EMD Serono and Pfizer Announce FDA Approval of Rebif Rebidose (interferon beta-1a)

The majority of patients found Rebif Rebidose easy to use in a user trial ROCKLAND, Mass. and NEW YORK, Jan. 3, 2013 /PRNewswire via COMTEX/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, ...
FiercePharma

FDA approves EMD Serono-Pfizer's Rebif auto-injector

The FDA has approved Rebif Rebidose, a single-use auto-injector prefilled with EMD Serono and Pfizer's ($PFE) interferon beta-1a, for the treatment of relapsing forms ...
Medscape

FDA Approves Interferon Autoinjector for MS

The US Food and Drug Administration has approved a single-use autoinjector (Rebidose, EMD Serono Inc./Pfizer Inc) for self-injection of interferon beta-1a (Rebif) in the treatment of relapsing forms ...
TASS

Merck to Present New Data on MS Portfolio: Rebif, Mavenclad, and Evobrutinib at ECTRIMS

DARMSTADT, Germany, October 18, 2017/PRNewswire/. Merck, a leading science and technology company, today announced that data for approved and investigational multiple sclerosis (MS) treatments, ...
Medscape

International Approvals: Tamiflu, Seroquel XR, Rebif

On September 20, the European Commission approved 30- and 45-mg strengths of oseltamivir phosphate capsules (Tamiflu, Hoffmann-La Roche Ltd) for the treatment and prevention of influenza types A and B ...
BioWorld

Serono’s Rebif Wins Approval; Biogen Gears Up For MS Fight

What Biogen says is that it plans to hang onto its lead in the U.S., and James Mullen, Biogen’s president and CEO, responded to the Rebif approval with a press release of Biogen’s own. Mullen called ...